OPEN Health adds David King to its Board of Directors as Non-Executive Chairman alongside Paul Carter joining as Independent Director

– UK, London –  OPEN Health, a leading global provider of scientific communication and market access services today announced the additions to its Board of Directors of David King as Non-Executive Chairman and Paul Carter as an independent director.

“We are delighted to welcome Dave and Paul to the OPEN Health board of directors, both stalwarts in the pharma ecosystem. Dave and Paul are experienced leaders with excellent track records in the healthcare and life sciences industry. Their leadership and market insights will help OPEN Health to continue to grow and scale,” said CEO, Rob Barker.

About David P. King

David King served for 13 years as chairman and CEO of LabCorp, where he spearheaded the company’s transformation from a pure-play clinical laboratory into a global leader in life sciences, tripling the size of the company to more than $11.5 billion in revenue and nearly 65,000 employees. David was critical in expanding offerings for pharmaceutical and biotech companies, including leading the acquisition of Covance. Today, LabCorp is a Fortune 250 company with over $15 billion in revenue and 75,000 employees, serving pharmaceutical companies, doctors, hospitals, researchers, and patients worldwide.

“I am honored to be appointed chairman of OPEN Health, and I am excited to partner with the management team and Astorg to support strengthening its position as a global leader in medical affairs and market access. OPEN Health’s strong customer relationships and deep commitment to science position it well for continued growth. I look forward to working with OPEN Health’s market-leading management team as they continue to provide innovative solutions to positively impact science, medicine, and patient lives,” said David King.

About Paul Carter

Paul Carter served as executive vice president and chief commercial officer at Gilead, where he oversaw unprecedented growth and commercial success in the US, Europe, Japan, and other geographies. In his prior role as head of commercial operations for international markets at Gilead, Mr. Carter built the Gilead commercial infrastructure across 38 countries over eight years.

Paul Carter said, “OPEN Health is a formidable company. I look forward to working with the board and management team to help guide the company’s development plan and further strengthen its position as a leading commercialization partner for pharma and biotech companies globally.”

About OPEN Health

OPEN Health unites deep scientific knowledge with wide-ranging specialist expertise to unlock possibilities that improve health outcomes and patient well-being. Working in partnership with our clients, we embrace our different perspectives and strengths to deliver fresh thinking and solutions that make a difference. OPEN Health is a flexible global organization that solves complex healthcare challenges across HEOR and market access, medical communications, and creative omnichannel campaigns.

For more information:

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.